Filtered By:
Drug: Dexamethasone
Therapy: Radiation Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion
This report may broaden the application of Dara-Rd for POEMS syndrome.PMID:36202948 | DOI:10.1007/s12185-022-03459-w
Source: International Journal of Hematology - October 6, 2022 Category: Hematology Authors: Takashi Oyama Kazuki Taoka Akira Chiba Yosuke Masamoto Masako Ikemura Akira Honda Hiroaki Maki Mineo Kurokawa Source Type: research
Non-secretory multiple myeloma expressed as multiple extramedullary plasmacytoma with an endobronchial lesion mimicking metastatic cancer: A case report
CONCLUSION: We present a rare case of non-secretory MM with multiple extramedullary plasmacytoma with an endobronchial lesion.PMID:36158506 | PMC:PMC9372843 | DOI:10.12998/wjcc.v10.i22.7899
Source: Clinical Lung Cancer - September 26, 2022 Category: Cancer & Oncology Authors: Seul Bi Lee Chi Young Park Hee Jeong Lee Ran Hong Woo Shin Kim Sang-Gon Park Source Type: research
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
CONCLUSION: RT administered concurrently with DCEP was well-tolerated by most of the patients in this series, with low rates of hematologic and RT-related toxicity. RT was also very effective, with the vast majority of patients demonstrating resolution of their pain and a significant response on follow-up imaging.PMID:34736880 | DOI:10.1016/j.clml.2021.09.015
Source: Clinical Lymphoma and Myeloma - November 5, 2021 Category: Cancer & Oncology Authors: Anthony D Nehlsen Kunal K Sindhu Erin Moshier Joshua Richter Shambavi Richard Ajai Chari Larysa Sanchez Samir Parekh Hearn Jay Cho Sundar Jagannath Kavita Dharmarajan Source Type: research
Whole-Lung Low-Dose Radiation Therapy (LD-RT) for Non-Intubated Oxygen-Dependent Patients with COVID-19-Related Pneumonia Receiving Dexamethasone and/or Remdesevir
CONCLUSIONS: Adding LD-RT to standard drug treatments reduced biomarkers of inflammation and cardiac injury in COVID-19 patients and may have reduced intubation. Durable CRP decline following LD-RT predicted especially favorable recovery, freedom from intubation, reduction in prolonged hospitalization, and reduced oxygenation burden. A confirmatory randomized trial is now ongoing.CLINICAL TRIAL REGISTRATION: NCT04366791.FUNDING: None.PMID:34653525 | PMC:PMC8511870 | DOI:10.1016/j.radonc.2021.10.003
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - October 15, 2021 Category: Radiology Authors: Clayton B Hess Tony Y Eng Tahseen H Nasti Vishal R Dhere Troy J Kleber Jeffrey M Switchenko Brent D Weinberg Nadine Rouphael Sibo Tian Md Soumon Rudra Luisa S Taverna Alvaro Perez Daisson Rafi Ahmed Mohammad K Khan Source Type: research
Pancreatic Cancer with Leptomeningeal Carcinomatosis: Case Presentation and Literature Review (P5.181)
Conclusions:Pancreatic cancer associated LMC is extremely rare. With increased systemic control, however, there may be increasing occurrence of LMC and/or parenchymal involvement. To date, as with LMC associated with other solid tumors, survival is poor.Study Supported by: Not applicableDisclosure: Dr. Perilla has nothing to disclose. Dr. Melian has nothing to disclose. Dr. Schneck has received research support from NIH (POINT, COSS, ARUBA, ALIAS, Lundbeck (DIAS4), TIMI-50 Consortium, and Local PI Multicenter Clincial trials
Source: Neurology - April 17, 2017 Category: Neurology Authors: Perilla, A. S., Melian, E., Schneck, M. Tags: Neuro-oncology: Brain and CNS Metastases Source Type: research
